Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma.

Fultang L, Gamble LD, Gneo L, Berry AM, Egan SA, De Bie F, Yogev O, Eden GL, Booth S, Brownhill S, Vardon A, McConville CM, Cheng PN, Norris MD, Etchevers HC, Murray J, Ziegler DS, Chesler L, Schmidt R, Burchill SA, Haber M, De Santo C, Mussai F.

Cancer Res. 2019 Feb 1;79(3):611-624. doi: 10.1158/0008-5472.CAN-18-2139. Epub 2018 Dec 13.

PMID:
30545920
2.

The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.

Farina AR, Cappabianca L, Ruggeri P, Gneo L, Pellegrini C, Fargnoli MC, Mackay AR.

J Exp Clin Cancer Res. 2018 Jun 18;37(1):119. doi: 10.1186/s13046-018-0786-3. Review.

3.

TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation.

Farina AR, Cappabianca L, Gneo L, Ruggeri P, Mackay AR.

Oncotarget. 2017 Dec 22;9(9):8368-8390. doi: 10.18632/oncotarget.23618. eCollection 2018 Feb 2.

4.
5.

NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis.

Ruggeri P, Cappabianca L, Farina AR, Gneo L, Mackay AR.

Cell Death Discov. 2016 Feb 1;2:16004. doi: 10.1038/cddiscovery.2016.4. eCollection 2016.

6.

NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells.

Ruggeri P, Cappabianca L, Farina AR, Gneo L, Mackay AR.

Cell Death Dis. 2016 Mar 10;7:e2139. doi: 10.1038/cddis.2016.49. No abstract available.

7.

Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity.

Farina AR, Cappabianca L, Ruggeri P, Gneo L, Maccarone R, Mackay AR.

Oncotarget. 2015 Nov 3;6(34):35636-51. doi: 10.18632/oncotarget.5802.

Supplemental Content

Support Center